Dr Tony Dhillon

University of Surrey and Royal Surrey County Hospital

Consultant medical oncologist and Senior Lecturer at the Royal Surrey and University of Surrey. Specialising in colon, liver, pancreas and biliary cancers. Research interests are in colon cancer immunotherapy and microbiome and pancreatic and colon cancer. Research collaborations with the Royal Marsden/Institute of Cancer Research and the University of Oxford. I am the chief investigator of the POLEM trial- phase 3 study of immunotherapy in MSI-High stage 3 Colon cancer.

dont miss

Immunotherapy and Colon Cancer

Discussion of the evidence of benefit of checkpoint inhibition in colon cancer, in particular in the adjuvant setting- discussing on going clinical trials and up to date data. Description of data in metastatic colon cancer and future directions


  • Rae Denman, and Dr Zoe Poole.: Speaking at the Oncology Convention

    Rae Denman, and Dr Zoe Poole.
    The British Association of Medical Tattooing (BAMT)

    Medical Tattooing: Regulating the industry

  • Dr Khurum Khan: Speaking at the Oncology Convention

    Dr Khurum Khan
    University College London Hospitals

    Translational research in GI Oncology- how to make progress?

  • Islam Elkonaissi: Speaking at the Oncology Convention

    Islam Elkonaissi
    The Royal Marsden NHS Foundation Trust

    The Multi-Specialty Challenge of Cancer Care

  • Dr Shanmugasundaram Ramkumar: Speaking at the Oncology Convention

    Dr Shanmugasundaram Ramkumar
    University Hospital Southampton NHS Foundation Trust

    Radiotherapy developments in management of recurrent rectal cancers

  • Dr Catherine Coyle: Speaking at the Oncology Convention

    Dr Catherine Coyle
    Christie Hospital NHS Foundation Trust

    Prostate Cancer- the non surgical oncologists view